News & Events

Neuroblastoma

Filter by:

Ashley’s childhood cancer diagnosis in 1985 inspires her still today

Oct. 14 holds a special place in the hearts of Marcy Anderson and her daughter Ashley. It’s a reminder of their resilience through uncertain times as it was on that date in 1986, that Ashley had her final chemotherapy treatment at Children’s Minnesota in St. Paul.

Neuroblastoma

A neuroblastoma is a malignant tumor that most frequently occurs in children under five years of age. It is the most common malignant abdominal tumor seen in children.

Solid Tumors Program

The solid tumor cancer program at Children's is one of the largest of its kind in the Upper Midwest. We diagnose and treat children with all types of solid tumors, including the following:

Brain and Spinal Cord Tumor Program

Resources

Patient and Family Education Materials If you need quick, clear info about a kids' health topic, we have it all!

Conditions and Services

The cancer and blood disorders team at Children's Minnesota has the training, knowledge and technology to treat a wide range of conditions. Nearly 900 children are admitted annually as inpatients to the Jim and Colleen Ryan Pediatric Cancer and Blood Disorders Center at Children's Minnesota in Minneapolis, making us the largest program in the upper midwest. And while we're known as a leader and innovator in the field of pediatric cancer and blood disorder treatment, we never forget that each patient is someone's child. Compassion always factors into our approach. We are on the journey with you, because we believe that better journeys lead to better outcomes.

Cancer and Blood Disorders

It can be frightening to hear that a child has cancer or a blood disorder. At Children's Minnesota, we're experts in treating the disease and supporting the patient and family. In addition to offering advanced, individualized care for newly diagnosed children, teens and young adults up to age 26 with cancers and blood disorders, we also provide innovative treatment for rare, relapsed and recurrent cancers.